Vaginitis and STIs: The right treatment begins with the right diagnosis

Learn more about how the BD Vaginal Panel and the BD CTGCTV2 assay can help decrease the number of recurrent visits, incorrect treatments and negative sequelae associated with vaginits and STIs.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD released findings from a survey conducted by The Harris Poll that indicate a significant gap in women’s knowledge about the primary causes of cervical cancer as well as the most effective means of prevention.
Cervical Cancer | News & Updates
Press Release: New Harris Poll Reveals Significant Gaps in Women's Knowledge About Cervical Cancer
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Cervical Cancer | Webinars & Videos
ReachMD: Genotype specific persistence: Looking beyond HPV 16
BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay